NEW YORK, Jan. 03, 2023 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 at 11:15 a.m. PT.
The live and archived webcast can be accessed under “Events & Presentations” in the Investor Relations section of the Company’s website at www.intracellulartherapies.com. Please log in approximately 5-10 minutes prior to the event to register and to download and install any necessary software.
About Intra-Cellular Therapies
Intra-Cellular Therapies is a biopharmaceutical company founded on Nobel prize-winning research that allows us to understand how therapies affect the inner-workings of cells in the body. The company leverages this intracellular approach to develop innovative treatments for people living with complex psychiatric and neurologic diseases. For more information, please visit www.intracellulartherapies.com.
Contact:
Intra-Cellular Therapies, Inc.
Juan Sanchez, M.D.
Vice President, Corporate Communications and Investor Relations
646-440-9333
Burns McClellan, Inc.
Lisa Burns
cradinovic@burnsmc.com
212-213-0006
MAULDIN, SC / ACCESSWIRE / June 6, 2024 / Xcelerate, Inc. (OTCQB:XCRT) today announced that…
PENSACOLA, Fla., June 6, 2024 /PRNewswire/ -- As our population ages, long-term care will become…
NEW YORK, June 6, 2024 /PRNewswire/ -- Mobile Health, a leader in occupational health services,…
REDDING, Calif., June 6, 2024 /PRNewswire/ -- According to a new market research report titled,…
Provides a consolidated approach to enterprise medical image connectivity. PLEASANTON, Calif., June 6, 2024 /PRNewswire/…
Leaders of parents' groups from across the country share their personal experiences with the harmful…